A combination of retinoic acid and proteasome inhibitors for the treatment of leukemias is potentially dangerous [1]

Blood

Volumn 94, Issue 5, 1999, Pages 1827-1828

  Wojcik, C ^a   Mlynarczuk, I ^a   Hoser, G ^a   Kawiak, J ^a   Stoklosa, T ^a   Golab, J ^a   Wilk, S ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; PROTEASOME INHIBITOR; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN; RETINOIC ACID RECEPTOR; SOLVENT;

ANIMAL CELL; APOPTOSIS; CELL CYCLE PHASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG WITHDRAWAL; LETTER; LEUKEMIA L 1210; LYMPHATIC LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELAPSE;

EID: 0033198661     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.5.1827     Document Type: Letter

References (10)